This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sporos Therapeutics, LLC. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: E Stein Esser: Innovator in Tetanus Vaccine Development
Introduction
E Stein Esser is a notable inventor based in Atlanta, GA, who has made significant contributions to the field of vaccine development. His innovative approach to preventing tetanus infection has led to the creation of a unique vaccine that offers a new method for administration and storage.
Latest Patents
E Stein Esser holds 1 patent for his invention titled "Single dose non-adjuvanted cutaneous tetanus vaccine and uses thereof." This patent describes a method for preventing or treating tetanus infection in a subject by administering a non-adjuvanted tetanus toxoid vaccine to the skin. The vaccine can be delivered through intradermal injection or a microneedle patch, eliminating the need for cold storage, which is a significant advancement in vaccine technology.
Career Highlights
Esser is currently associated with Sporos Therapeutics, LLC, where he continues to work on innovative solutions in the field of immunization. His career reflects a commitment to enhancing public health through scientific research and development.
Collaborations
Throughout his career, E Stein Esser has collaborated with esteemed colleagues, including Ioanna Skountzou and Richard W Compans. These partnerships have contributed to the advancement of his research and the successful development of his patented vaccine.
Conclusion
E Stein Esser's work in developing a non-adjuvanted tetanus vaccine represents a significant step forward in immunization practices. His innovative methods and dedication to public health continue to inspire advancements in vaccine technology.